Is a 2-week regimen of tecovirimat sufficient for the treatment of Mpox (monkeypox) in advanced HIV patients with a low CD4 cell count?

Research output: Contribution to journal › Journal article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{41c5cf1e5b184c4bb918928f5e3ad012,

title = "Is a 2-week regimen of tecovirimat sufficient for the treatment of Mpox (monkeypox) in advanced HIV patients with a low CD4 cell count?",

author = "Jeong-Hwan Hwang and Joo-Hee Hwang",

year = "2024",

month = may,

day = "14",

language = "Korean",

journal = "Journal of Medical Virology",

issn = "0146-6615",

}